Form 8-K - Current report:
SEC Accession No. 0001104659-25-041204
Filing Date
2025-04-29
Accepted
2025-04-29 16:05:27
Documents
13
Period of Report
2025-04-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513421d1_8k.htm   iXBRL 8-K 30758
  Complete submission text file 0001104659-25-041204.txt   208027

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA trda-20250429.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE trda-20250429_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trda-20250429_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2513421d1_8k_htm.xml XML 3811
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40969 | Film No.: 25887124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)